vimarsana.com
Home
Live Updates
Class of Diabetes Drugs May Reduce Colorectal Cancer Risk : comparemela.com
Class of Diabetes Drugs May Reduce Colorectal Cancer Risk
A class of medications used to treat type 2 diabetes, called GLP1 receptor agonists, may also reduce the risk of colorectal cancer, a new study shows.
Related Keywords
United States ,
American ,
Rong Xu ,
Nathan Berger ,
National Institutes Of Health ,
Case Western Reserve University ,
American Cancer Society ,
Technology Network ,
School Of Medicine ,
Case Western Reserve School Of Medicine ,
Case Comprehensive Cancer Center ,
Hanna Payne Professor ,
Experimental Medicine ,
Case Western Reserve School ,
Case Comprehensive Cancer ,
National Institutes ,
comparemela.com © 2020. All Rights Reserved.